Verastem (NASDAQ:VSTM) Downgraded by StockNews.com

StockNews.com lowered shares of Verastem (NASDAQ:VSTM – Free Report) from a hold rating to a sell rating in a research report sent to investors on Friday morning. Other analysts have also issued reports about the stock. HC Wainwright restated a buy rating and issued a $17.50 price target on shares of Verastem in a research […]

Leave a Reply

Your email address will not be published.

Previous post Sportradar Group (NASDAQ:SRAD) Given New $12.00 Price Target at Morgan Stanley
Next post StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD)